Medicine guide

Corlanor

7.5 mg · Tablet, Film Coated

  • Prescription only
  • Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
Active substance
Ivabradine
Made by
Amgen Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Ivabradine). It describes the substance, not this exact product.

Ivabradine blocks the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel responsible for the cardiac pacemaker I f current, which regulates heart rate.

In clinical electrophysiology studies, the cardiac effects were most pronounced in the sinoatrial (SA) node, but prolongation of the AH interval has occurred as has PR interval prolongation.

Half-life2 h
Mostly cleared after≈ 10 hfive half-lives — our arithmetic
How the body breaks it down

Ivabradine is extensively metabolized in the liver and intestines by CYP3A4-mediated oxidation.

How it leaves the body

The total clearance of ivabradine is 24 L/h, and renal clearance is approximately 4.2 L/h, with ~ 4% of an oral dose excreted unchanged in urine.

With food

Food delays absorption by approximately 1 hour and increases plasma exposure by 20% to 40%.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-24

Safety of the active substance

From the US prescribing label for the same active substance (Ivabradine). It describes the substance, not this exact product.

Must not be used by
  • Ivabradine is contraindicated in patients with:.
  • Acute decompensated heart failure.
  • Clinically significant hypotension.
  • Sick sinus syndrome, sinoatrial block or 3 rd degree AV block, unless a functioning demand pacemaker is present.
Most common side effects

Most common adverse reactions occurring in ≥ 1% of patients are bradycardia, hypertension, atrial fibrillation and luminous phenomena (phosphenes).

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byAmgen Inc
Active substanceIvabradine
Strength7.5 mg
FormTablet, Film Coated
RouteOral
Packs60 TABLET, FILM COATED in 1 BOTTLE
NDC55513-810

Source: NDC Directory · 2026-09-13 · not reviewed by a clinician

Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).

Other strengths and forms

3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

  • Tablet, Film Coated2 products
  • Solution1 products

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.